Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion type Assertion NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_head.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion description "[Here we report that BCL-2 protein expression of human glial tumors in vivo correlates with malignant transformation in that BCL-2 immunoreactive glioma cells were more abundant in WHO grade III/IV gliomas than in grade I/II gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion evidence source_evidence_literature NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion SIO_000772 7539458 NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion wasDerivedFrom befree-20140225 NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.
- NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_assertion wasGeneratedBy ECO_0000203 NP862372.RA3fVRTCA67Fv7gKr2mB5JfgsAy3BNDg89npLxAaNXQsY130_provenance.